id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1975-N-0017-0052,FDA,FDA-1975-N-0017,Supplement from McNeil Consumer Healthcare (Response to Request for Information),Other,Supplement (SUP),2010-08-13T04:00:00Z,2010,8,2010-08-13T04:00:00Z,,2018-01-30T14:59:35Z,,0,0,0900006480b2f0ce
FDA-1975-N-0017-0053,FDA,FDA-1975-N-0017,"New Clinical Data on Acetaminophen/Diphenhydramine Combination Products as a Nighttime Sleep-Aid Drug Product for OTC Use re McNeil Consumer Healthcare - Comment, FDA-1975-N-0017-0051",Supporting & Related Material,C-Comment (Supporting and Related Material),2010-08-13T04:00:00Z,2010,8,,,2013-04-12T15:56:31Z,,0,0,0900006480b2ffbf
FDA-1975-N-0017-0054,FDA,FDA-1975-N-0017,Table of Contents - Study Numbers... Combination of OTC Nighttime Sleep-Aid and OTC Internal Analgesic(s): Data Supporting Category 1 Designation - [McNeil Consumer Healthcare (Response to Request for Information) - Supplement] re FDA-1975-N-0017-0052 re: Supplement from McNeil Consumer Healthcare (Response to Request for Information),Supporting & Related Material,Studies and Reports,2010-08-13T04:00:00Z,2010,8,,,2018-01-05T14:58:01Z,,0,0,0900006480b2f0cf
FDA-1975-N-0017-0050,FDA,FDA-1975-N-0017,See FDA-1975-N-0017-0028,Rule,NFR-Notice of Final Rule,2010-04-09T04:00:00Z,2010,4,2010-04-09T04:00:00Z,,2011-02-08T14:46:37Z,,0,0,0900006480ad3b5e
FDA-1975-N-0017-0049,FDA,FDA-1975-N-0017,FDA/CDER to Consumer Healthcare Products Association - Response Letter,Other,LET-Letter,2010-02-17T05:00:00Z,2010,2,2010-02-17T05:00:00Z,,2013-08-11T03:06:52Z,,0,0,0900006480aa6a63
FDA-1975-N-0017-0047,FDA,FDA-1975-N-0017,Protocol Review from Nonprescription Drug Manufacturers Association,Other,Protocol Review,2010-01-21T05:00:00Z,2010,1,2010-01-21T05:00:00Z,,2018-01-02T18:08:41Z,,0,0,09000064805c2428